Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years
Clinical trial NCT00783653 · COMPLETED
Trial details
- NCT number
- NCT00783653
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2013-07-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.